Abrahamsson Annelie, Rzepecka Anna, Dabrosin Charlotta
Department of Oncology, Linköping University, Linköping, Sweden.
Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Front Immunol. 2018 Jan 16;8:1994. doi: 10.3389/fimmu.2017.01994. eCollection 2017.
The inflammatory microenvironment affects breast cancer progression. Proteins that govern the inflammatory response are secreted into the extracellular space, but this compartment still needs to be characterized in human breast tissues . Dense breast tissue is a major risk factor for breast cancer by yet unknown mechanisms and no non-toxic prevention for these patients exists. Here, we used the minimal invasive technique of microdialysis for sampling of extracellular proteins in live tissues in breast cancers of women before surgery and in healthy women having dense or non-dense breast tissue on mammography. Proteins were profiled using a proximity extension assay. Out of the 32 proteins assessed, 26 exhibited similar profiles in breast cancers and dense breast tissues; CCL-4, -7, -8, -11, -15, -16, -22, -23, and -25, CXCL-5, -8, -9, -16 as well as sIL-6R, IL-18, vascular endothelial growth factor, TGF-α, fibroblast growth factor 19, matrix metalloproteinase (MMP)-1, -2, -3, and urokinase-type plasminogen activator were all increased, whereas CCL-3, CX3CL1, hepatocyte growth factor, and MMP-9 were unaltered in the two tissues. CCL-19 and -24, CXCL-1 and -10, and IL-6 were increased in dense breast tissue only, whereas IL-18BP was increased in breast cancer only. Our results provide novel insights in the inflammatory microenvironment in human breast cancer and define potential novel therapeutic targets. Additionally, we show previously unrecognized similarities of the pro-inflammatory microenvironment in dense breast tissue and breast cancer suggesting that anti-inflammatory breast cancer prevention trials for women with dense breast tissue may be feasible.
炎症微环境影响乳腺癌的进展。调控炎症反应的蛋白质分泌到细胞外空间,但该区域在人类乳腺组织中仍有待表征。致密乳腺组织是乳腺癌的主要危险因素,但其机制尚不清楚,且尚无针对这些患者的无毒预防措施。在此,我们采用微透析这一微创技术,对手术前女性乳腺癌患者以及乳腺钼靶检查显示为致密或非致密乳腺组织的健康女性的活体组织中的细胞外蛋白质进行采样。使用邻近延伸分析对蛋白质进行分析。在评估的32种蛋白质中,有26种在乳腺癌和致密乳腺组织中表现出相似的谱型;趋化因子配体(CCL)-4、-7、-8、-11、-15、-16、-22、-23和-25,趋化因子配体(CXCL)-5、-8、-9、-16以及可溶性白细胞介素-6受体(sIL-6R)、白细胞介素-18、血管内皮生长因子、转化生长因子-α、成纤维细胞生长因子19、基质金属蛋白酶(MMP)-1、-2、-3和尿激酶型纤溶酶原激活剂均增加,而CCL-3、CX3CL1、肝细胞生长因子和MMP-9在这两种组织中未发生改变。CCL-19和-24、CXCL-1和-10以及白细胞介素-6仅在致密乳腺组织中增加,而白细胞介素-18结合蛋白仅在乳腺癌中增加。我们的结果为人类乳腺癌的炎症微环境提供了新的见解,并确定了潜在的新治疗靶点。此外,我们发现致密乳腺组织和乳腺癌中促炎微环境存在以前未被认识到的相似性,这表明针对致密乳腺组织女性的抗炎性乳腺癌预防试验可能是可行的。